country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-183277

Copy Link Print Information

EGFR-IN-209

EGFR-IN-209 (Compound 6g) is an orally active, selective EGFR^{Del19/T790M/C797S} inhibitor with an IC₅₀ of 0.056 μM. EGFR-IN-209 blocks the phosphorylation of EGFR and its downstream effector molecules (pMAPK, pAKT). EGFR-IN-209 induces Apoptosis. EGFR-IN-209 exhibits antitumor activity against Osimertinib (HY-15772)-resistant non-small cell lung cancer. EGFR-IN-209 can be used in research related to non-small cell lung cancer.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No.: 3088042-00-3
화학식: C₂₁H₂₅N₅O
분자량:363.46

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

EGFR-IN-209 Chemical Structure

CAS No.: 3088042-00-3

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Use of MCE Products

One-stop solution for XDC (ADC/PDC/RDC/ApDC/FDC/ISAC/VDC/SMDC)

Biological Activity
- 제품 설명
- IC₅₀ & Target
- In Vitro
- Parmacokinetics
- In Vivo
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

IC₅₀ & Target

^[1]

EGFR^{del19 T790M C797S}

0.056 μM (IC₅₀)

All EGFR Isoforms :

All p38 MAPK Isoforms :

All Akt Isoforms :

In Vitro

EGFR-IN-209 (30 min) potently inhibits purified EGFR^{Del19/T790M/C797S} kinase, with an IC₅₀ of 0.056 μM^[1].
EGFR-IN-209 (100-300 nM; 24 h) potently inhibits the viability of PC-9^{Del19/T790M/C797S} cells, with an IC₅₀ value of 0.143 μM^[1].
EGFR-IN-209 (100-300 nM; 24-48 h) inhibits the migration of PC-9^{Del19/T790M/C797S} cells in scratch wound healing assays^[1].
EGFR-IN-209 (0.5-1.5 μM) inhibits the activation of EGFR and its downstream AKT/MAPK signaling pathway in PC-9^{Del19/EGFRT790M/C797S} cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

PC-9Del19/T790M/C797S non-small cell lung cancer cells
Concentration:

100, 300 nM
Incubation Time:

24 h
Result:

Inhibited the viability of PC-9Del19/T790M/C797S cells with an IC₅₀ of 0.143 μM.
Was 16-fold more potent than Osimertinib (IC₅₀ = 2.266 μM).

Cell Migration Assay ^[1]

Cell Line:

PC-9Del19/T790M/C797S non-small cell lung cancer cells
Concentration:

100, 300 nM
Incubation Time:

24 h, 48 h
Result:

Inhibited the migration of PC-9^{Del19/T790M/C797S} cells, as evidenced by reduced closure of the scratch wound over time.

Parmacokinetics

Species	Dose	Route	Bioavailability
Rat^[1]	10 mg/kg	p.o.	22.33 %

In Vivo

EGFR-IN-209 (5-10 mg/kg; p.o.; daily) achieves dose-dependent tumor growth inhibition in osimertinib (HY-15772)-resistant NSCLC xenograft models^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

NCG mice (male, 6 weeks old)^[1]
Dosage:

5 mg/kg; 10 mg/kg
Administration:

p.o.; daily
Result:

Achieved tumor growth inhibition (TGI) of 47.3%.
Achieved tumor growth inhibition (TGI) of 64.2%.
Showed no significant systemic toxicity.

Chemical Information

CAS No. 3088042-00-3
분자량 363.46
화학식 C₂₁H₂₅N₅O
SMILES

OC1=CC=CC=C1C2=NC(NCCN3CCN(C)CC3)=C4C=CC=CC4=N2
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Handling Instructions (2659 KB)

References

[1]. Chang H, et al. Structure-guided discovery of a potent 2-aryl-4-aminoquinazoline-based inhibitor overcoming osimertinib resistance driven by EGFR C797S mutation in NSCLC. Eur J Med Chem. 2026;311:118818. [Content Brief]

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기

Amount: USD 0.00

Biological Activity
- 제품 설명
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
순도&문서
References

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent:

상품명:
CAS No.:
Species:
Purity:
수량:

EGFR-IN-209

All EGFR Isoforms

All p38 MAPK Isoforms

All Akt Isoforms